Sign in
8-K

Current Report

CRISPR Therapeutics AG Filed Acc 0001564590-19-046006

Material agreement · Agreement ended · Acquisition or sale completed

  • Item 1.01 Entry into a material definitive agreement
  • Item 1.02 Termination of a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets

From the SEC's structured data for this filing

Loading crsp-8k_20191213.htm…